Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for NCNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 4.310M
March 31, 2026 4.162M
December 31, 2025 4.162M
September 30, 2025 4.162M
June 30, 2025 1.908M
March 31, 2025 0.0303M
December 31, 2024 0.0283M
September 30, 2024 3.925M
June 30, 2024 2.246M
March 31, 2024 2.246M
December 31, 2023 2.094M
September 30, 2023 2.092M
June 30, 2023 2.076M
March 31, 2023 2.076M
December 31, 2022 2.075M
September 30, 2022 2.068M
June 30, 2022 2.068M
Date Value
March 31, 2022 2.068M
December 31, 2021 2.067M
September 30, 2021 2.067M
June 30, 2021 2.066M
March 31, 2021 2.066M
December 31, 2020 2.027M
September 30, 2020 2.027M
June 30, 2020 1.298M
March 31, 2020 1.279M
December 31, 2019 1.279M
September 30, 2019 1.278M
June 30, 2019 1.270M
March 31, 2019 1.269M
December 31, 2018 1.269M
September 30, 2018 0.0063M
June 30, 2018 1.272M
March 31, 2018 0.0063M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
Mereo BioPharma Group Plc 159.62M
BioNTech SE 251.20M
Silence Therapeutics Plc 141.74M
Autolus Therapeutics Plc 266.16M